Integra LifeSciences Holdings Corporation Dividend History (IART)
Integra LifeSciences Holdings Corporation does not pay dividends currently 😔
They might in the future, check back soon!
About Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a prominent global medical technology company with a focus on developing life-saving and life-enhancing medical devices and cosmeceuticals. Founded in 1989, Integra is headquartered in Princeton, New Jersey. The company specializes in products for surgery, neurosurgery, and regenerative medicine, serving healthcare providers in more than 100 countries. As of 2023, Jan De Witte serves as the CEO of the company. Integra is known for its innovative solutions, such as advanced surgical instruments, wound care products, and neuro-critical care tools. With an annual revenue exceeding $1 billion, Integra continues to impact patient care worldwide while maintaining a strong commitment to research, development, and sustainability.
Apple Inc.
Microsoft Corporation
Johnson & Johnson
Procter & Gamble Co.
Coca-Cola Co.
PepsiCo, Inc.
Exxon Mobil Corporation
Verizon Communications Inc.
AT&T Inc.
Chevron CorporationBeam Therapeutics, a biotechnology company developing precision genetic medicines, has appointed Sravan K. Emany as its new Chief Financial Officer. Emany brings extensive experience in the life sciences industry and will help guide Beam's growth and capital allocation strategy.
GlobeNewswire Inc. · Published on Fri Dec 06 2024The chronic wound care market is expected to grow at a CAGR of 4.17% from 2024 to 2031, driven by the high prevalence of chronic diseases and advancements in wound care technologies. The market is segmented by product, application, end-user, and region, with North America leading due to its developed healthcare infrastructure.
Benzinga · Published on Tue Nov 26 2024The global orthobiologics market is expected to grow from $7.1 billion in 2024 to $11.7 billion by 2033, driven by the rising prevalence of musculoskeletal diseases and the increasing demand for minimally invasive treatments.
GlobeNewswire Inc. · Published on Mon Nov 11 2024